Reproduction and longevity A Mendelian randomization study of gonadotropin-releasing hormone and ischemic heart disease
Abstract
BackgroundAccording to well-established evolutionary biology theory reproduction trades-off against longevity, implying that upregulating the reproductive axis might drive major diseases. We assessed whether the central driver of reproduction gonadotropin-releasing hormone 1 (GnRH1) had a causal effect on the leading cause of global morbidity and mortality, i.e. ischemic heart disease (IHD). As a contrast we similarly examined the role of GnRH2 because it is more a driver of female sexual behavior.\n\nMethodsWe applied strong (p-value <5x10-6) and independent genetic predictors of GnRH1 and GnRH2 to an extensively genotyped IHD case (n=76,014) - control (n=264,785) study using multiplicative random effects inverse variance weighted (IVW), weighted median, MR-Egger and MR-PRESSO estimates.\n\nResultsGnRH1, predicted by 11 genetic variants, was positively associated with IHD (IVW odds ratio (OR) 1.04 per effect size, 95% confidence interval (CI) 1.01 to 1.08), but GnRH2, predicted by 15 genetic variants, was not (IVW OR 0.98, 95% CI 0.95 to 1.02).\n\nConclusionsGnRH1 is a potential IHD genetic target. Apart from demonstrating a central tenet of evolutionary biology in humans, our study suggests that existing treatments and environmental factors targeting GnRH1, its drivers or consequences could be re-purposed to prevent and treat IHD. Given, the importance of reproduction to the human species, many such exposures likely exist.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Apolipoprotein B and Interleukin 1 Receptor Antagonist: Reversing the Risk of Coronary Heart Disease
Fangkun Yang, Ning Huangfu, … Shuai Yuan·Frontiers in EndocrinologyPeer-reviewed·Oct 24, 2023
- GLP1R expression protects against 58 diseases but raises risk for 34 diseases and neonatal health
Robert H Campbell, Melinda C Mills·medRxiv·Feb 18, 2026
- Associations of endogenous and exogenous hormonal exposures and cardiovascular disease in women - A FinnGen study
Tia-Marje K. Korhonen, Takiy-Eddine Berrandou, … Eija K. Laakkonen·medRxiv·Mar 14, 2026
- Human genetics suggests differing causal pathways from HMGCR inhibition to coronary artery disease and type 2 diabetes
Seongwon Hwang, Ville Karhunen, … Stephen Burgess·International Journal of EpidemiologyPeer-reviewed·Dec 25, 2025
- GWAS identifies novel risk locus for erectile dysfunction and implicates hypothalamic neurobiology and diabetes in etiology
Jonas Bovijn, Leigh M. Jackson, … Michael Vaclav Holmes·The American Journal of Human GeneticsPeer-reviewed·Dec 21, 2018
- Exploring repositioning opportunities and side-effects of statins: a Mendelian randomization study of HMG-CoA reductase inhibition with 55 complex traits
Hon‐Cheong So, Carlos Kwan‐Long Chau, Kai Zhao·bioRxiv·Dec 23, 2017